FDA To Withdraw Approval Of Controversial Preterm Pregnancy Drug Makena
SILVER SPRING, Md. — The Food and Drug Administration on Oct. 5 notified AMAG Pharma USA Inc. and five other drug companies that the agency is proposing to withdraw approval of...To view the full article, register now.
Already a subscriber? Click here to view full article